Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.Bruce W. Dana, R I Fisher, Thomas P. Miller et al.|Journal of Clinical Oncology|1993Cited by 193